BruceDouglasSmithMD

PubMed

• 3 citations
  Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
  Khaled Sanber, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A Webster, Ivana Gojo, Gabriel Ghiaur, Gabrielle T Prince, Lukasz P Gondek, B Douglas Smith, Mark J Le...> ;Leukemia & Lymphoma. 2023 Apr 1
• 2 citations
  Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.
  Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph ...> ;Clinical Cancer Research. 2023 Jun 13
• 3 citations
  Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
  Michael J Hochman, B Douglas Smith, Theodoros Karantanos, Evan M Braunstein, Ivana Gojo, Tania Jain, Michael B Streiff, Alison R Moliterno, Amy E DeZern> ;International Journal of Hematology. 2023 Mar 1
• 8 citations
  Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.
  Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, Amy E DeZern, Gabriel Ghiaur, W Brian Dalton, Ivana Gojo, Gabrielle T Prince, Jonathan Webster, Alexander Ambinde...> ;Leukemia & Lymphoma. 2022 Aug 1
• 57 citations
  Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
  Daniel A Pollyea, Courtney D DiNardo, Martha L Arellano, Arnaud Pigneux, Walter Fiedler, Marina Konopleva, David A Rizzieri, B Douglas Smith, Atsushi Shinagawa, Robert...> ;Clinical Cancer Research. 2022 Jul 1
• 10 citations
  Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study.
  Guillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, Mohammed Farooqui, Patricia Marinello, B Douglas Smith> ;Leukemia & Lymphoma. 2022 Jul 1
• 11 citations
  Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
  Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
• 11 citations
  Venetoclax exposure-efficacy and exposure-safety relationships in patients with treatment-naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.
  Deanna Brackman, Doerthe Eckert, Rajeev Menon, Ahmed Hamed Salem, Jalaja Potluri, B Douglas Smith, Andrew H Wei, John Hayslip, Dale Miles, Sven Mensing, Sathej Gopalak...> ;Hematological Oncology. 2022 Apr 1
• 1 citations
  Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis.
  Jose Tinajero, Khaled El-Shami, Xiaojun Wu, B Douglas Smith, Matthew J Newman> ;Leukemia Research Reports. 2022 Jan 1
• 3 citations
  A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
  Jonathan Webster, Tara M. Robinson, Amanda L. Blackford, Erica D. Warlick, Anna Ferguson, Ivan Borrello, Marianna Zahurak, Richard J. Jones, B. Douglas Smith> ;Leukemia Research. 2021 Nov 2
• 3 citations
  A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
  Joshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy, Aziz Nazha, Jordi Esteve, Daniel J. Lee, Karen W.L. Yee, Andrew Dalovisio, Eunice S. Wang, Jua...> ;Blood Cancer Journal. 2021 Oct 30
• 8 citations
  Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies.
  Stephen Jolles, B. Douglas Smith, Donald C. Vinh, Rajiv Mallick, Gabriela Espinoza, Mitchell DeKoven, Victoria Divino> ;Leukemia & Lymphoma. 2021 Oct 26
• 4 citations
  Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
  Alexander J. Ambinder, Matthew D. Smith, Hua-Ling Tsai, Ravi Varadhan, Amy E. DeZern, William Dalton, Christian B. Gocke, Jonathan Webster, Lukasz P. Gondek, Ivana Goj...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Oct 9
• 2 citations
  Infections in secondary immunodeficiency patients treated with Privigen® or Hizentra®: a retrospective US administrative claims study in patients with hematological ma...
  Rajiv Mallick, Victoria Divino, B. Douglas Smith, Stephen Jolles, Mitchell DeKoven, Donald C. Vinh> ;Leukemia & Lymphoma. 2021 Sep 27
• 5 citations
  Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults w...
  Hetty E. Carraway, Yazeed Sawalha, Ivana Gojo, Min-Jung Lee, Sunmin Lee, Yusuke Tomita, Akira Yuno, Jackie Greer, B. Douglas Smith, Keith W. Pratz, Mark J. Levis, Stev...> ;Leukemia Research. 2021 Sep 10
• 37 citations
  Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
  Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon, Alec D. Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A....> ;Blood Cancer Discovery. 2021 Sep 10
• 3 citations
  A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transpl...
  Jonathan Webster, Meera Yogarajah, Marianna Zahurak, Heather J. Symons, Amy E. DeZern, Ivana Gojo, Gabrielle T. Prince, Jillian Morrow, Richard J. Jones, B. Douglas Sm...> ;Leukemia & Lymphoma. 2021 Jul 21
• Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II r...
  Michael Heuser, B. Douglas Smith, Walter Fiedler, Mikkael A. Sekeres, Pau Montesinos, Brian Leber, Akil Merchant, Cristina Papayannidis, José A. Pérez-Simón, Caroline ...> ;Annals of Hematology. 2021 Jul 1
• 5 citations
  Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
  Kyle Zacholski, Bryan C. Hambley, Erin Hickey, Sarah M. Kashanian, Andrew Y. Li, Maria R. Baer, Vu H. Duong, Matthew J Newman, Amy E. DeZern, Ivana Gojo, B. Douglas Sm...> ;Journal of Oncology Pharmacy Practice. 2021 Jun 17
• 2 citations
  CDK2-mediated upregulation of TNFa as a mechanism of selective cytotoxicity in acute leukemia
  Husheng Ding, Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam, X. Wei Meng, Paula A. Schneider, Karen S. Flatten, Ke...> ;Cancer Research. 2021 May 15
• 24 citations
  Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
  Michael Heuser, B Douglas Smith, Walter Fiedler, Mikkael A Sekeres, Pau Montesinos, Brian Leber, Akil Merchant, Cristina Papayannidis, José A Pérez-Simón, Caroline J H...> ;Annals of Hematology. 2021 May 1
• 2 citations
  FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
  Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Ivana Gojo, Jonathan Webster, Kelly J. Norsworthy, B ...> ;Biology. 2021 Mar 21
• 1 citations
  Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass
  Amy S. Duffield, Jonathan Webster, B. Douglas Smith, Julius S. Necciai, Austin McCuiston, Alisha D. Ware> ;Head and Neck Pathology. 2021 Feb 22
• 7 citations
  Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study.
  Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, Ravi Varadhan, Dan Ariely, Vered Stearns, B. Douglas Smith, Thomas J. Smith, Benjamin W. Corn> ;JCO Oncology Practice. 2021 Feb 17
• 4 citations
  Increased body mass index is a risk factor for acute promyelocytic leukemia.
  Sarah M. Kashanian, Andrew Y. Li, Moaath Mustafa Ali, Mark E. Sutherland, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Firas El Chaer, Noa G. Holtzman, Mohammad Imra...> ;Ejhaem. 2021 Jan 6
• Join now to see all

Lectures

• Low-dose cytarabine with or without glasdegib in newly diagnosed patients with acute myeloid leukemia: Long-term analysis of a phase 2 randomized trial. 
  2019 ASCO Annual Meeting - 6/1/2019